Infinity Biologix: Robin Grimwood, Other Senior Team Members
Infinity Biologix has named Robin Grimwood as CEO; Isabella Britton as head of people; Aaron Venables as vice president of commercial, international; Ali Fawz as deputy general counsel; Gary Price as head of regulatory affairs and quality assurance; and Scott Waksman and director of finance and corporate development.
Grimwood previously served as interim CEO and is also a cofounder of the Infinity Biologix. He has more than 20 years of experience in the life sciences market including in areas such as biobanking, sample storage and tracking, 2D coded tubes, compound management, robotics, high-throughput screening, consumer genomics, and liquid handling.
Britton most recently was executive director of human resources at Celgene. Venables joins the company from Fluidic Analytics, where he was chief commercial officer, and he previously worked for companies including Illumina and Thermo Fisher Scientific. Fawaz most recently served as executive director at Celgene, and prior to that was a partner at Proskauer Rose. Price previously served as a senior director of quality assurance and regulatory affairs for international and joint ventures at Infinity Biologix. Waksman joins the company from Thomson Reuters where he held a number of roles including VP, head of finance for the Investing and Advisory division.